NPR's Sarah Chayes reports that an Indian pharmaceutical company, Cipla, Ltd., has offered to sell the humanitarian group Doctors without Borders anti-AIDS drugs at a fraction of market price. Cipla says it will provide a three-drug therapy for a cost of $350 per patient per year. In the United States this three-drug cocktail costs more than ten thousand dollars a year, a price that's completely out of reach for patients in the developing world.
Copyright 2001 NPR